Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 24, 2023

SELL
$160.2 - $179.79 $8,330 - $9,349
-52 Reduced 1.79%
2,859 $0
Q3 2022

Oct 31, 2022

SELL
$161.33 - $179.52 $16,133 - $17,952
-100 Reduced 3.32%
2,911 $476,000
Q2 2022

Jul 25, 2022

BUY
$168.19 - $186.01 $42,383 - $46,874
252 Added 9.13%
3,011 $534,000
Q1 2022

May 03, 2022

SELL
$158.14 - $179.59 $1,423 - $1,616
-9 Reduced 0.33%
2,759 $489,000
Q4 2021

Feb 08, 2022

BUY
$155.93 - $173.01 $15,593 - $17,301
100 Added 3.75%
2,768 $474,000
Q3 2021

Oct 25, 2021

BUY
$161.5 - $179.47 $430,882 - $478,825
2,668 New
2,668 $431,000
Q1 2021

Apr 26, 2021

SELL
$153.07 - $170.48 $434,718 - $484,163
-2,840 Closed
0 $0
Q3 2020

Oct 27, 2020

SELL
$140.38 - $153.83 $3,088 - $3,384
-22 Reduced 0.77%
2,840 $423,000
Q1 2020

May 05, 2020

SELL
$111.14 - $153.99 $20,560 - $28,488
-185 Reduced 6.07%
2,862 $375,000
Q4 2019

Feb 03, 2020

SELL
$127.5 - $146.44 $9,945 - $11,422
-78 Reduced 2.5%
3,047 $444,000
Q3 2019

Oct 30, 2019

SELL
$126.95 - $142.14 $1,777 - $1,989
-14 Reduced 0.45%
3,125 $404,000
Q2 2019

Jul 31, 2019

BUY
$131.15 - $144.24 $8,787 - $9,664
67 Added 2.18%
3,139 $437,000
Q1 2019

Apr 25, 2019

SELL
$125.72 - $139.79 $4,903 - $5,451
-39 Reduced 1.25%
3,072 $429,000
Q3 2018

Oct 31, 2018

SELL
$121.58 - $142.88 $174,588 - $205,175
-1,436 Reduced 31.58%
3,111 $430,000
Q2 2018

Jul 27, 2018

SELL
$119.4 - $131.76 $274,620 - $303,048
-2,300 Reduced 33.59%
4,547 $552,000
Q1 2018

Apr 25, 2018

SELL
$125.1 - $148.14 $50,915 - $60,292
-407 Reduced 5.61%
6,847 $877,000
Q4 2017

Jan 30, 2018

SELL
$131.22 - $143.62 $18,370 - $20,106
-140 Reduced 1.89%
7,254 $1.01 Million
Q3 2017

Nov 01, 2017

BUY
$129.47 - $135.38 $957,301 - $1 Million
7,394
7,394 $961,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $404B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Capital Management Corp Portfolio

Follow Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Capital Management Corp with notifications on news.